Price $44.18 |
Market Cap
256B
|
Sector Health Care |
Div. Growth
4.80%
|
|
P/E
17.9
|
P/B
3.61
|
P/S
4.72
|
Dividend %
3.20%
|
|
P/CF
-
|
P/FCF
38.6
|
Op. Cash Flow
16.86M
|
FCF
1.1
|
|
Op. Margin
24.50%
|
Net Margin
40.70%
|
ROE
32.00%
|
ROI
11.00%
|
|
ROA
12.90%
|
EPS Growth
160.60%
|
Current Ratio
1.4
|
Debt/Equity
47.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Hologic, Inc. (HOLX) | $41.57 | - | - | 10.91B | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.19 | - | - | 40.1M | Strong Buy |
| Oncolytics Biotech, Inc. (USA) (ONCY) | $2.53 | - | - | 49.2M | Strong Buy |
| Correvio Pharma Corp (CORV) | $3.26 | - | - | 122.4M | Strong Buy |
| Community Health Systems (CYH) | $3.46 | - | - | 388.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
